{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Peter", "organization": "", "rank": 1, "lastname": "EAVIS"}], "original": "By PETER EAVIS"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [], "headline": {"main": "Ackman Sheds Some Valeant Shares"}, "print_page": null, "keywords": [{"value": "Pershing Square Capital Management", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "Valeant Pharmaceuticals International Inc", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Ackman, William A", "is_major": "N", "rank": "3", "name": "persons"}, {"value": "Hedge Funds", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Pearson, John Michael (1959- )", "is_major": "N", "rank": "6", "name": "persons"}], "snippet": "William Ackman\u2019s hedge fund said in a regulatory filing that its stake was now 8.5 percent, down from 9.9 percent, of the drug company that has been drawing fire on several fronts.", "source": "The New York Times", "lead_paragraph": "William Ackman\u2019s hedge fund said in a regulatory filing that its stake was now 8.5 percent, down from 9.9 percent, of the drug company that has been drawing fire on several fronts.", "word_count": "350", "pub_date": "2016-01-01T00:00:00Z", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/01/01/business/dealbook/ackman-sheds-some-valeant-shares.html", "_id": "5685d12638f0d85a6c13020b"}